APA

Lubenow N., Warkentin T. E., Greinacher A., Wessel A., Sloane D., Krahn E. L. & Magnani H. N. (20060919). Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift in clinical practice during the 1990s. : Thrombosis research.

Chicago

Lubenow Norbert, Warkentin Theodore E, Greinacher Andreas, Wessel Antje, Sloane Debi-Ann, Krahn Erica L and Magnani Harry N. 20060919. Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift in clinical practice during the 1990s. : Thrombosis research.

Harvard

Lubenow N., Warkentin T. E., Greinacher A., Wessel A., Sloane D., Krahn E. L. and Magnani H. N. (20060919). Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift in clinical practice during the 1990s. : Thrombosis research.

MLA

Lubenow Norbert, Warkentin Theodore E, Greinacher Andreas, Wessel Antje, Sloane Debi-Ann, Krahn Erica L and Magnani Harry N. Results of a systematic evaluation of treatment outcomes for heparin-induced thrombocytopenia in patients receiving danaparoid, ancrod, and/or coumarin explain the rapid shift in clinical practice during the 1990s. : Thrombosis research. 20060919.